MedPath

CARVYKTI

CARVYKTI

Approved
DIN Number

02535270

Drug Class

Human

Market Date

N/A

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02535270
AIG Number0164442001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01XL05 CILTACABTAGENE AUTOLEUCEL
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CILTACABTAGENE AUTOLEUCELActive
Strength: 100000000 CELLS / BAG
Monograph: CILTACABTAGENE AUTOLEUCEL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.